Cita APA

Ueda, M., Tanimoto, T., Murayama, A., Ozaki, A., & Kami, M. (2021). Japan’s Drug Regulation During the COVID‐19 Pandemic: Lessons From a Case Study of Favipiravir. Clin Pharmacol Ther.

Chicago Style Citation

Ueda, Munetaka, Tetsuya Tanimoto, Anju Murayama, Akihiko Ozaki, i Masahiro Kami. "Japan’s Drug Regulation During the COVID‐19 Pandemic: Lessons From a Case Study of Favipiravir." Clin Pharmacol Ther 2021.

Cita MLA

Ueda, Munetaka, et al. "Japan’s Drug Regulation During the COVID‐19 Pandemic: Lessons From a Case Study of Favipiravir." Clin Pharmacol Ther 2021.